/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
+0.09%
Natural Gas
-1.90%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+0.35%
VIX
N/A
Economic Calendar
EUR/USD
+0.09%
Natural Gas
-1.90%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+0.35%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
Michigan Consumer Sentiment Rises To 71.8, Missing Analyst Expectations
3 days ago
Composite PMI Rises To 55.3, Beating Analyst Expectations
3 days ago
UK PMI Drops Below 50: Manufacturing and Services Hit 13-Month Lows in November
3 days ago
Eurozone PMI Hits 10-Month Low as Services Join Manufacturing in Contraction
3 days ago
Germany’s Services Sector Contracts as Manufacturing PMI Stays Deep in Contraction
3 days ago
UK Retail Sales Drops by 0.7% in October Sparking Rate Cut Debate
3 days ago
Crypto Recharged Over the Weekend
27 minutes ago
Holiday-Shortened Week Could See Big Swings as PCE Inflation Shapes Fed Outlook
about 1 hour ago
US Dollar Forecast: Strong PMI Boosts DXY, FOMC Minutes Ahead – Gold, GBP/USD, EUR/USD Outlook
about 3 hours ago
Silver (XAG) Daily Forecast: Will $30.74 Hold, or Is a Break Below Imminent?
about 3 hours ago
Gold (XAU) Daily Forecast: Risk-On Sentiment Pressures Prices Below $2,660
about 4 hours ago
Natural Gas and Oil Forecast: WTI Holds at $71 Amid Strong Demand from China and India
about 4 hours ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
APLS
news
Apellis Pharmaceuticals Inc
Follow
APLS
(
Nasdaq - US
)
Closed
30.76
+3.01 (+10.85%)
in
:
usd
•
As of: Nov 22, 2024 15:59
UTC -5
After Market
:
30.83
+0.07 (+0.23%)
Open
28.00
High
30.99
Low
27.92
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
Latest News
Zacks Investment Research
Nov 6, 2024
Apellis' Q3 Loss Wider Than Expected, Syfovre Drives Revenues Y/Y
APLS
+10.85%
The Motley Fool
Nov 5, 2024
Why Apellis Pharmaceuticals Stock Was Tumbling on Tuesday
APLS
+10.85%
Seeking Alpha
Nov 5, 2024
Apellis Pharmaceuticals, Inc. (APLS) Q3 2024 Earnings Call Transcript
APLS
+10.85%
Zacks Investment Research
Nov 5, 2024
Apellis Pharmaceuticals (APLS) Reports Q3 Earnings: What Key Metrics Have to Say
APLS
+10.85%
Zacks Investment Research
Nov 5, 2024
Apellis Pharmaceuticals, Inc. (APLS) Reports Q3 Loss, Lags Revenue Estimates
APLS
+10.85%
Zacks Investment Research
Oct 29, 2024
Will Apellis Pharmaceuticals, Inc. (APLS) Report Negative Earnings Next Week? What You Should Know
APLS
+10.85%
The Motley Fool
Oct 29, 2024
1 Nasdaq Stock Down 62% This Year That Could Double Your Money, According to a Wall Street Analyst
APLS
+10.85%
Benzinga
Oct 16, 2024
Syfovre's Competitive Edge Highlights Bright Future For Apellis Pharmaceuticals, Analyst Initiates With Bullish Pitch
APLS
+10.85%
24/7 Wall Street
Oct 9, 2024
Prediction: This Will Be the Best-Performing Growth Stock Over the Next 5 Years
APLS
+10.85%
Seeking Alpha
Oct 4, 2024
Apellis: Weighing Syfovre's Rapid Expansion Against Risks In The GA Market (Rating Upgrade)
APLS
+10.85%
Seeking Alpha
Oct 1, 2024
Apellis Pharmaceuticals: Assessing The Impact Of The Negative CHMP Opinion
APLS
+10.85%
Zacks Investment Research
Sep 23, 2024
Apellis Stock Down as Eye Drug Faces Third CHMP Rejection in the EU
APLS
+10.85%
Investors Business Daily
Sep 20, 2024
Apellis Stock Hammered After Eye Drug Gets A Third European Rejection
APLS
+10.85%
InvestorPlace
Aug 13, 2024
Wedbush Just Raised its Price Target on These 7 Stocks: August 12, 2024
CYBR
-3.00%
Seeking Alpha
Aug 9, 2024
Apellis: Rare Kidney Disease Data Leads To Possible First To Market
APLS
+10.85%
Benzinga
Aug 8, 2024
Apellis Pharmaceuticals' Pegcetacoplan Meets Primary Goal In Late-Stage Study In Patients With Rare Kidney Diseases
APLS
+10.85%
Seeking Alpha
Aug 1, 2024
Apellis Pharmaceuticals, Inc. (APLS) Q2 2024 Earnings Call Transcript
APLS
+10.85%
Zacks Investment Research
Aug 1, 2024
Apellis (APLS) Q2 Earnings Beat, Syfovre Sales Drive Revenues
APLS
+10.85%
Zacks Investment Research
Aug 1, 2024
Compared to Estimates, Apellis Pharmaceuticals (APLS) Q2 Earnings: A Look at Key Metrics
APLS
+10.85%
Zacks Investment Research
Aug 1, 2024
Apellis Pharmaceuticals, Inc. (APLS) Reports Q2 Loss, Tops Revenue Estimates
APLS
+10.85%
Stocks
Popular
Currencies
Commodities
Indices
Stocks
ETFs
Crypto
Watchlist
Loading
Loading
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker